Fabrication of Bioengineered Skin by Injection Molding: A Feasibility Study on Automation.


Journal

SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 30 6 2019
medline: 18 4 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

The use of bioengineered skin has facilitated fundamental and applied research because it enables the investigation of complex interactions between various cell types as well as the extracellular matrix. The predominantly manual fabrication of these living tissues means, however, that their quality, standardization, and production volume are extremely dependent on the technician's experience. Simple laboratory automation could facilitate the use of living tissues by a greater number of research groups. We developed and present here an injection molding technique for the fabrication of bilayered skin equivalents. The tissue was formed automatically by two separate injections into a customized mold to produce the dermal and epidermal skin layers. We demonstrated the biocompatibility of this fabrication process and confirmed the resulting bilayered morphology of the bioengineered skin using histology and immunohistochemistry. Our findings highlight the possibility of fabricating multilayered living tissue by injection molding, suggesting that further investigation into this automation method could result in the rapid and low-cost fabrication of standardized bioengineered skin.

Identifiants

pubmed: 31251675
doi: 10.1177/2472630319857966
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-514

Auteurs

S Fox (S)

Product Development Group Zurich pd|z, Department of Mechanical and Process Engineering, ETH Zürich, Zürich, Switzerland.

J Polak (J)

Product Development Group Zurich pd|z, Department of Mechanical and Process Engineering, ETH Zürich, Zürich, Switzerland.

M Schmid Daners (M)

Product Development Group Zurich pd|z, Department of Mechanical and Process Engineering, ETH Zürich, Zürich, Switzerland.

M Meboldt (M)

Product Development Group Zurich pd|z, Department of Mechanical and Process Engineering, ETH Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH